Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults

Clinical trial NCT04530487 · TERMINATED

Trial details

NCT number: NCT04530487
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Desmoplastic Small Round Cell Tumor Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Recurrent Desmoplastic Small Round Cell Tumor Recurrent Malignant Peripheral Nerve Sheath Tumor Recurrent Malignant Solid Neoplasm Recurrent Neuroblastoma Recurrent Rhabdomyosarcoma Refractory Desmoplastic Small Round Cell Tumor Refractory Malignant Peripheral Nerve Sheath Tumor Refractory Malignant Solid Neoplasm Refractory Neuroblastoma Refractory Rhabdomyosarcoma

Start date: 2020-08-19
Primary completion: 2024-08-26
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.